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Insulin releases inositol phosphoglycans from myocytes in culture [(1986) Science 233,967-9721, which display insulino- 
mimetic activity. Because S’nucleotidase is anchored to the membrane through inositol-containing phospholipid glycans, 
we investigated whether insulin could release the enzyme from the membrane. Membranes prepared from hindquarter 
muscles of rats perfused with insulin showed a 23% decrease in S-nucleotidase activity. Isolated membranes from muscle 
exposed to insulin in vitro also showed a small but reproducible decrease (9%) in S-nucleotidase activity relative to unex- 
posed controls. Phospholipase C from Staphylococcus aureus released m of the membrane-bound S-nucleotidase. We 
propose that insulin may activate an endogenous phospholipase C that cleaves phospholipid-glycan-anchored proteins. 
S’-Nucleotidase; Insulin action; Anchored protein; (Skeletal muscle) 
1. INTRODUCTION 
In skeletal muscle, insulin stimulates glucose 
transport, oxidation and incorporation into 
glycogen. Considerable progress has been made in 
the last two years regarding the identification of 
water-soluble mediators [l-3] that stimulate 
glycogen synthase phosphatase [4] and mimic 
several other actions of insulin [ 1,5,6] even in in- 
tact cells [5]. These purported insulin mediators 
are inositol-containing phosphoglycans (IPG) pro- 
duced by phospholipase C (PL-C) hydrolysis of 
phospholipid-glycans present in B&H1 myocytes 
[ 11, liver membranes [2] or H35 hepatoma cells [3]. 
They have been equated to the ‘polar head groups’ 
isolated from insulin-treated BCsH 1 myocytes [l] 
or H35 hepatoma cells [3], which are generated 
roughly in a 1: 1 ratio to diacylglycerol [ 11. 
In cell membranes, IPGs are found in 
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phosphatidylinositol-glycans (phospholipid-gly- 
cans) and in phosphatidylinositol-glycan-ethanol- 
amine-proteins (henceforth referred to as phos- 
pholipid-glycan-proteins) (review [7]). Membrane 
proteins anchored to the membrane through phos- 
pholipid-glycans include 5 ’ -nucleotidase and 
alkaline phosphatase (reviews [8,17]). The IPGs 
released by the action of insulin could arise from 
hydrolysis of either phospholipid-glycans or 
phospholipid-glycan-proteins. The nature of the 
parent compound(s) that are insulin-sensitive has 
yet to be elucidated. For IPGs to be derived from 
phospholipid-glycans a single cleavage by a PL-C 
would suffice. In contrast, for IPGs to be derived 
from phospholipid-glycan-proteins, a second 
cleavage by a protease would seem necessary for 
protein removal (see [9]). 
Generation of IPGs can also be induced by addi- 
tion of PL-C from Staphylococcus aureus, sug- 
gesting that insulin may activate an endogenous 
PL-C akin to that from bacteria. Indeed, an 
insulin-sensitive PL-C activity has been detected in 
fat cells [lo]. In addition to generating IPGs, the 
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hypothetical insulin-dependent PL-C could poten- 
tially release IPG-ethanolamine proteins. This 
could change the protein composition of cell mem- 
branes. Moreover, the released proteins, if endow- 
ed with enzymatic activity, could act at a site 
distinct from the cell of origin. It is not known 
whether insulin can release anchored membrane 
enzymes. This study describes the effect of insulin 
in situ and in vitro on 5 ’ -nucleotidase activity in 
skeletal muscle membranes. 
2. MATERIALS AND METHODS 
2.1. Animals and perfused hindlimb preparation 
Male Sprague-Dawley rats weighing 250-350 g were fasted 
overnight prior to experiments, and surgical preparation of the 
hindquarter with placement of catheters in the abdominal aorta 
and inferior vena cava was performed essentially as in [ 11,121. 
Hindlimbs were perfused with 50 ml oxygenated Krebs- 
Henseleit bicarbonate buffer (pH 7.4) containing 4 g/100 ml 
bovine serum albumin and 8 mM glucose, followed by 20 min 
perfusion with 0 or lOOOpU/ml porcine insulin (20 ml/min). 
An approx. 5-fold increase in the rate of glucose uptake 
(arterial-venous difference) was observed in response to in- 
sulin. Immediately after perfusion the muscles of both 
hindlimbs were dissected out, trimmed of fat and connective 
tissue while kept on ice, frozen in liquid Nz and kept at - 70°C 
until used for preparation of membranes. 
2.2. Membrane preparation and enzyme activities 
Muscle membrane isolation was carried out exactly as 
described in [12] by differential centrifugation and separation 
on sucrose gradients. The membranes isolated on top of 25% 
sucrose were washed by dilution in 10 mM NaHCOs (pH 7.0), 
0.25 M sucrose, 5 mm NaNr, 0.1 mM phenylmethylsulfonyl 
fluoride (PMSF) and centrifuged at 190000 x g for 60 min. The 
membranes were resuspended in medium of the same composi- 
tion and stored frozen at - 120°C. This fraction was previously 
shown to contain purified plasma membranes [12], based on its 
enrichment in the plasma membrane markers phospho- 
diesterase I and Mg’+-ATPase (>3-fold increase over crude 
membranes) and absence of the sarcoplasmic reticulum marker 
Cazf-dependent ATPase [12]. Protein content was determined 
by the dye-binding procedure of Bradford [13]. Liver mem- 
branes were prepared by a modification of the method of Song 
et al. [14]. 
5 ‘-Nucleotidase was assayed as described by Song and 
Bodansky [15]. Briefly, 25 pg protein were incubated with 
5 mM AMP in 0.1 M Tris-HCl (pH 8.3) containing 10 mM 
MgClz for 30 min at 37°C. Phosphate production was 
measured by reaction with ammonium molybdate and FeS04. 
Plasma membrane Mg’+-ATPase was assayed as in [la]; 
alkaline phosphatase (pH 10.3) was assayed as in [17] using 
bis(p-nitrophenyl) phosphate as substrate. Adenyl cyclase was 
measured as in [18]. 
Insulin action in vitro: membranes (1 mg protein) were in- 
cubated in a final volume of 25 ml without or with 1 ,uM insulin 
in 2 mM MgClr, 10 mM NaHCOr, 7 mM CaCl2, 1 mM ATP 
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for 30 min at 37°C. During incubation, 1 mM ATP was re- 
added every 10 min (deemed necessary to maintain activity of 
the insulin receptor tyrosine kinase). Membranes were then cen- 
trifuged at 190000 x g for 60 min and used for determinations 
of protein, 5 ’ nucleotidase and alkaline phosphatase. 
Treatment with PL-C from S. aureus (spec. act. 
100 pmol/min per ml towards phosphatidylinositol bis- 
phosphate, kindly provided by Dr M. Low and Dr M. 
Moscarello): 50~1 membranes in the NaHCOs/sucrose con- 
taining PMSF and NaNp were mixed with 50 ,ul of 0.1 M Tris 
(pH 7.4) containing 2 mM EGTA & PL-C for 30 min at 37°C. 
The membranes were then pelleted in an airfuge at maximal 
velocity for 10 min. The 5’-nucleotidase activities of both com- 
plete pellet and supernatant were immediately determined as 
described above. 
3. RESULTS 
3.1. 5 ‘-Nucleotidase activity in isolated plasma 
membranes from muscles of insulin-treated 
rats 
We have previously shown that perfusion of 
hindquarter muscles with insulin results in the 
migration of glucose transporters from an in- 
tracellular membrane fraction to the plasma mem- 
brane [12]. This was concluded from the observed 
increase in number of glucose transporters 
(detected as glucose-protectable cytochalasin B- 
binding sites) in the isolated plasma membranes, 
and concomitant decrease in the number of 
transporters in an isolated fraction containing in- 
tracellular membranes. Those observations in- 
dicate that changes that occur during perfusion 
with the hormone can be retained in the isolated 
membranes. Here, we examine the activity of 
5 ’ -nucleotidase in plasma membranes isolated 
from control and insulin-perfused muscles. The 
protein yield of the isolated membranes was not 
significantly different in insulin and control 
preparations (57 f 9 and 57 f 7 pg/g tissue, 
respectively, each n = 8). Table 1 lists the activity 
of 5 ‘-nucleotidase in 10 control and 10 membrane 
preparations. This activity was decreased by an 
average of 23 +- 6% by the insulin treatment. In 8 
of the 10 pairs of membrane preparations, 
Mg’+-ATPase activity (another plasma membrane 
marker [12,16]) was also measured (table 1). The 
average Mg’+-ATPase activity was not significant- 
ly different in the control and insulin-treated 
group. In one set of membranes from control and 
insulinized animals, forskolin-activated adenyl 
cyclase activity was also measured. This activity 
was 9.4 pmol/mg per h in control membranes and 
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Table 1 Table 2 
Effect of in situ insulin on 5’-nucleotidase and Mg*+-ATPase 
activities 
Effect of in vitro insulin on the activities of 5 ’ -nucleotidase and 
alkaline phosphatase 
5 ’ -Nucleotidase Mg*+-ATPase 
Control 365 + 23 2589 + 436 
(10) (8) 
Insulin 213 + 15 2451 f 331 
(10) (8) 
A(Contro1 - insulin) 92 f 23 138 f 351 
(10) (8) 
p (paired) <0.005 *0.05 
p (not paired) <O.OOl SO.05 
(Z/C) - 1 0.23 f 0.06 0.06* ~0.14 
(10) (8) 
Plasma membranes were prepared from skeletal muscles of 
control and insulinized animals (see section 2). The activities of 
5 ’ nucleotidase and Mg*+-ATPase were subsequently 
measured. Results are given in nmol/min per mg protein, 
expressed as means f SE of (n) independent membrane 
preparations, each assayed in triplicate. (Z/C’) - 1 represents the 
averaged fractional decrease in activity caused by insulin 
5 ’ -Nucleotidase Alkaline phosphatase 
A (Control - insulin) 17.3 f 3.9 570 + 120 
t 4.436 4.75 
n 4 4 
P < 0.025 < 0.025 
(Z/c) - 1 0.092 + 0.026 0.125 f 0.043 
Plasma membranes were prepared from skeletal muscle of 
control animals, and then exposed in vitro to 0 or 1 PM insulin 
(see section 2). The activities of 5’-nucleotidase and alkaline 
phosphatase were subsequently determined. Results are of n = 
4 independent membrane preparations, each assayed in 
triplicate. A, mean of the differences between paired control 
and insulin-treated samples, in nmol/min per mg protein. The 
statistical parameters of Student’s t-test for paired data are 
included. (Z/C) - 1, fractional change in insulin-treated 
samples relative to controls 
19.9 pmol/mg per h in membranes from insulin- 
treated rats. This activity represented a 1.8- and 
2.3-fold enrichment, respectively, relative to crude 
microsomes. Thus, the insulin-dependent decrease 
in 5 ’ -nucleotidase is not due to a generalized 
decrease in other membrane marker enzymes. 
be tissue-specific. Exposure of isolated membranes 
from rat liver to insulin failed to elicit a decrease 
in 5 ‘-nucleotidase activity: 103 f 3 nmol/min per 
mg protein in control, and 97 + 7 nmol/min per 
mg protein in insulin-treated membranes. 
3.3. Effect of phospholipase C of S. aureus on 
5 ‘-nucleotidase activity 
3.2. 5 ‘-Nucleotidase activity in membranes from 
skeletal muscle treated with insulin in vitro 
Table 2 shows the result of the in vitro action of 
insulin on isolated muscle membranes. Membranes 
were exposed to the hormone as described in sec- 
tion 2. The activity of 5 ‘-nucleotidase in insulin- 
treated membranes was decreased by an average of 
9.2 k 2.6% vs that in untreated membranes. In the 
same membrane preparations, the activity of 
another phospholipid-glycan-protein, alkaline 
phosphatase, was also significantly decreased (12.5 
+ 4.3%) by insulin. These results confirm the ef- 
fects of insulin in the perfused muscle, and further 
suggest hat the effect of the hormone of decreas- 
ing selective enzymatic activities in the plasma 
membrane does not require an intact cell. 
Therefore, presumably all the components 
necessary to elicit a decrease in 5 ’ -nucleotidase or 
alkaline phosphatase activities are present in the 
isolated membranes. 
The small but significant decrease in 
5 ’ -nucleotidase activity caused by insulin could be 
due to release of anchored enzyme. To calculate 
the maximum amount of enzyme that is anchored 
through phospholipid-glycans, membranes from 
control skeletal muscle were treated with PL-C 
from S. aureus. When 3Opg membrane protein 
were thus treated and centrifuged, 5 ’ -nucleotidase 
activity in the pellet decreases by 60% (from 319 to 
124 nmol/30 min). The activity lost was nearly 
quantitatively recovered in the supernatant 
(225 nmol/30 min in supernatants of PL-C-treated 
vs 28 nmol/30 min in those of untreated mem- 
branes) . 
4. DISCUSSION 
The effect of insulin reported above appears to 
4.1. Possible mechanisms of insulin-mediated 
decrease in 5 ‘-nucleotidase activity 
The results of this study indicate that in situ 
treatment with insulin results in a 23% loss of 
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5’-nucleotidase activity in plasma membranes 
isolated from skeletal muscles of the rat hind- 
quarter. This effect is mimicked to some extent by 
incubating control membranes in the presence of 
insulin in vitro (9’70 decrease in enzyme activity). 
60% of 5 ’ -nucleotidase activity can also be re- 
leased from muscle membranes by exogenous PL- 
C. Therefore, assuming that the insulin-mediated 
decrease in 5 ’ -nucleotidase activity results from 
hormonal activation of an endogenous PL-C, it 
can be calculated that insulin releases 42% in situ 
and 15% in vitro of the total releasable 
5 ’ -nucleotidase (i.e. of the total activity releasable 
by exogenous PL-C). 
An alternative explanation might be that insulin 
inhibits the membrane-bound 5 ’ -nucleotidase. To 
establish whether the hormone induces release of 
enzyme from the membranes, one needs to test the 
aqueous medium for 5 ’ -nucleotidase activity. Un- 
fortunately, this cannot be done in the in situ per- 
fusion experiments. Also, the activity of this 
enzyme in the supernatant of in vitro insulin- 
treated membranes could not be assessed ue to in- 
terference by ATP with the 5 ’ -nucleotidase assay. 
Therefore, at present, the suggestion that the 
insulin-dependent decrease in activity of this en- 
zyme is mediated by an endogenous PL-C relies on 
the analogy of the hormonal effect to the effect of 
exogenous PL-C . 
To our knowledge, there are no reports that 
demonstrate an insulin-dependent release of an- 
chored proteins through the activation of en- 
dogenous PL-C. However, circumstantial evidence 
suggesting this possibility has been recently 
published: Levy et al. [19] reported a decrease in 
the total activity of alkaline phosphatase in rat 
osteoblastic cells after chronic (24 h) insulin treat- 
ment. Similarly, the content of heparan sulfate 
proteoglycan, another anchored protein, was 
lowered by exposure of cells to insulin for 12 h 
[20]. The nature of the association of that protein 
with the membrane, however, remains controver- 
sial [21]. It was suggested recently that alkaline 
phosphatase may be released from intact cells by 
insulin through the activation of an unidentified 
cellular protease [22]. We believe that the decrease 
in membrane-bound 5 ‘-nucleotidase activity 
reported in our study is not the exclusive result of 
proteolysis, since PMSF, a serine protease in- 
hibitor, was present during all incubations. 
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4.2. Significance of the insulin-dependent 
decrease in 5 ‘-nucleotidase activity 
The present results indicate that in rat skeletal 
muscle membranes there is an insulin-dependent 
decrease in the activity of 5 ‘-nucleotidase. The 
physiological significance of this finding remains 
to be determined. However, it is intriguing that the 
levels of 5 ‘-nucleotidase are 3-fold higher in 
adipocytes from diabetic (streptozotocin-treated) 
rats than in control animals, and that this activity 
decreases to close to normal values following in- 
cubation of intact adipocytes with insulin or 
following in vivo insulin treatment of diabetic 
animals [23]. Thus, it is tempting to suggest hat 
insulin decreases the level of membrane-bound 
5’-nucleotidase in vivo, and that this hormonal 
regulation of the enzyme may be abnormal in 
insulin-deficient states (e.g. diabetes). 
In summary, we have shown that insulin 
decreases 5’ -nucleotidase activity in plasma mem- 
branes from insulin-treated muscle, as well as in 
plasma membranes exposed in vitro to the hor- 
mone. If the decrease is due to the liberation of an- 
chored protein molecules this would constitute 
evidence that insulin can activate the hydrolysis of 
phospholipid-glycan-proteins. In addition, the 
results suggest caution in the use of 
5 ’ -nucleotidase as a plasma membrane marker, 
since different metabolic conditions may result in 
loss of the enzyme from otherwise pure plasma 
membranes. 
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